These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 11576344
1. Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy. Suga S, Kim YG, Joly A, Puchacz E, Kang DH, Jefferson JA, Abraham JA, Hughes J, Johnson RJ, Schreiner GF. Kidney Int; 2001 Oct; 60(4):1297-308. PubMed ID: 11576344 [Abstract] [Full Text] [Related]
2. Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kim YG, Suga SI, Kang DH, Jefferson JA, Mazzali M, Gordon KL, Matsui K, Breiteneder-Geleff S, Shankland SJ, Hughes J, Kerjaschki D, Schreiner GF, Johnson RJ. Kidney Int; 2000 Dec; 58(6):2390-9. PubMed ID: 11115072 [Abstract] [Full Text] [Related]
3. Nitric oxide modulates vascular disease in the remnant kidney model. Kang DH, Nakagawa T, Feng L, Johnson RJ. Am J Pathol; 2002 Jul; 161(1):239-48. PubMed ID: 12107108 [Abstract] [Full Text] [Related]
4. Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy. Keller K, Daniel C, Schöcklmann H, Endlich KH, Kerjaschki D, Johnson RJ, Hugo C. Nephrol Dial Transplant; 2006 Oct; 21(10):2724-35. PubMed ID: 16861242 [Abstract] [Full Text] [Related]
5. The time course of tumor necrosis factor-alpha, inducible nitric oxide synthase and vascular endothelial growth factor expression in an experimental model of chronic myocardial infarction in rats. Heba G, Krzemiński T, Porc M, Grzyb J, Ratajska A, Dembińska-Kieć A. J Vasc Res; 2001 Oct; 38(3):288-300. PubMed ID: 11399901 [Abstract] [Full Text] [Related]
8. Down-regulation of renal endothelial nitric oxide synthase expression in experimental glomerular thrombotic microangiopathy. Zhou XJ, Laszik Z, Ni Z, Wang XQ, Brackett DJ, Lerner MR, Silva FG, Vaziri ND. Lab Invest; 2000 Jul; 80(7):1079-87. PubMed ID: 10908153 [Abstract] [Full Text] [Related]
9. VEGF(165) mediates glomerular endothelial repair. Ostendorf T, Kunter U, Eitner F, Loos A, Regele H, Kerjaschki D, Henninger DD, Janjic N, Floege J. J Clin Invest; 1999 Oct; 104(7):913-23. PubMed ID: 10510332 [Abstract] [Full Text] [Related]
10. Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Masuda Y, Shimizu A, Mori T, Ishiwata T, Kitamura H, Ohashi R, Ishizaki M, Asano G, Sugisaki Y, Yamanaka N. Am J Pathol; 2001 Aug; 159(2):599-608. PubMed ID: 11485918 [Abstract] [Full Text] [Related]
11. A new model of renal microvascular endothelial injury. Nangaku M, Alpers CE, Pippin J, Shankland SJ, Adler S, Kurokawa K, Couser WG, Johnson RJ. Kidney Int; 1997 Jul; 52(1):182-94. PubMed ID: 9211361 [Abstract] [Full Text] [Related]
12. Relation between expression of TNF alpha, iNOS, VEGF mRNA and development of heart failure after experimental myocardial infarction in rats. Heba G, Krzemiński T, Porc M, Grzyb J, Dembińska-Kieć A. J Physiol Pharmacol; 2001 Mar; 52(1):39-52. PubMed ID: 11321512 [Abstract] [Full Text] [Related]
13. Protective role of nitric oxide in a model of thrombotic microangiopathy in rats. Shao J, Miyata T, Yamada K, Hanafusa N, Wada T, Gordon KL, Inagi R, Kurokawa K, Fujita T, Johnson RJ, Nangaku M. J Am Soc Nephrol; 2001 Oct; 12(10):2088-2097. PubMed ID: 11562407 [Abstract] [Full Text] [Related]
14. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Kang DH, Anderson S, Kim YG, Mazzalli M, Suga S, Jefferson JA, Gordon KL, Oyama TT, Hughes J, Hugo C, Kerjaschki D, Schreiner GF, Johnson RJ. Am J Kidney Dis; 2001 Mar; 37(3):601-11. PubMed ID: 11228186 [Abstract] [Full Text] [Related]
15. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation. Pala L, Cresci B, Manuelli C, Maggi E, Yamaguchi YF, Cappugi P, Rotella CM, Giannini S. Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941 [Abstract] [Full Text] [Related]
16. Evaluation of the mechanism of vascular endothelial growth factor improvement of ischemic flap survival in rats. Pang Y, Lineaweaver WC, Lei MP, Oswald T, Shamburger S, Cai Z, Zhang F. Plast Reconstr Surg; 2003 Aug; 112(2):556-64. PubMed ID: 12900614 [Abstract] [Full Text] [Related]
17. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH. J Am Soc Nephrol; 2001 May; 12(5):993-1000. PubMed ID: 11316858 [Abstract] [Full Text] [Related]
19. Inducible nitric oxide synthase-derived nitric oxide promotes glomerular angiogenesis via upregulation of vascular endothelial growth factor receptors. Ostendorf T, Van Roeyen C, Westenfeld R, Gawlik A, Kitahara M, De Heer E, Kerjaschki D, Floege J, Ketteler M. J Am Soc Nephrol; 2004 Sep; 15(9):2307-19. PubMed ID: 15339980 [Abstract] [Full Text] [Related]
20. A murine model of site-specific renal microvascular endothelial injury and thrombotic microangiopathy. Hohenstein B, Braun A, Amann KU, Johnson RJ, Hugo CP. Nephrol Dial Transplant; 2008 Apr; 23(4):1144-56. PubMed ID: 18045820 [Abstract] [Full Text] [Related] Page: [Next] [New Search]